Meta-analysis of an AR-regulated gene signature specific to benign prostate epithelia shows that it is consistently reduced or lost in prostate cancer: the degree of loss increases with tumour grade (Stuchbery et al. 2016). The gene discussed is AR; the disease is prostate cancer.